Blue Ridge Buffettologist
Contributor since: 2013
Latest Articles
Top 20 Reasons Valeant Is A Buy At Current Levels
An Open Letter To Valeant's Michael Pearson
Controversy Regarding Ex-CEO Shkreli And Drug Price Gouging Could Imperil Retrophin's Business Model
Heron Therapeutics: Caveat Emptor
An Open Letter To Michael Kors's CEO, John Idol
Oil And Gas Stocks: Buy When People Are Fearful
A Strange Situation At Retrophin Becomes Even More Bizarre
Retrophin: Additional Red Flags Signal Extreme Caution For Investors
Why Tesla's Heavily-Promoted Shares Could Prove To Be Fool's Gold
Loews Corporation: An Underperforming Conglomerate In Search Of An Activist
Tesla: 4 Reality Checks For Bulls To Consider
Retrophin: The Curious Case Of The Missing Term Loan Agreement
Retrophin: An Analysis Of The Recent Capital Raise And Portfolio Acquisition
Retrophin: An Attractive Short Candidate Due To Numerous Red Flags
Tower Group: An Arbitrage Opportunity With A Potential Annualized Return Over 100%
Why Tesla Will Slowly Lose Credibility With The Market
Tesla - 20 Key Risks That Longs Are Ignoring
Correcting Some Misperceptions Regarding J.C. Penney's Liquidity And Q4 Earnings
J. C. Penney: Free Cash Flow And Liquidity Scenarios For 2014
The Coca-Cola Company: Unlocking Value In 2014 And Beyond
J.C. Penney: Valuation Perspectives On A Battleground Stock